SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-221762
Filing Date
2024-09-19
Accepted
2024-09-19 07:17:25
Documents
3
Period of Report
2024-09-19

Document Format Files

Seq Description Document Type Size
1 6-K d862804d6k.htm 6-K 10916
2 EX-99.1 d862804dex991.htm EX-99.1 13186
3 GRAPHIC g862804g0919011039016.jpg GRAPHIC 3168
  Complete submission text file 0001193125-24-221762.txt   29777
Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40299 | Film No.: 241309086
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)